Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

TAK1/MAP4K2 inhibitor 1

😃Good
Catalog No. T10444Cas No. 1315330-11-0

TAK1/MAP4K2 inhibitor 1 (compound 5) is a dual kinase inhibitor of TAK1 and MAP4K2 with IC50 values of 41.1 nM and 18.2 nM, respectively.

TAK1/MAP4K2 inhibitor 1

TAK1/MAP4K2 inhibitor 1

😃Good
Catalog No. T10444Cas No. 1315330-11-0
TAK1/MAP4K2 inhibitor 1 (compound 5) is a dual kinase inhibitor of TAK1 and MAP4K2 with IC50 values of 41.1 nM and 18.2 nM, respectively.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$1235 days5 days
5 mg$3995 days5 days
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products. However, due to objective factors, there is a small probability that the synthesis may not be successful during the R&D process. We appreciate your understanding. If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.
Questions
TargetMol
View More

Batch Information

Select Batch
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
TAK1/MAP4K2 inhibitor 1 (compound 5) is a dual kinase inhibitor of TAK1 and MAP4K2 with IC50 values of 41.1 nM and 18.2 nM, respectively.
Targets&IC50
TAK1:41.1 nM, MAP4K2:18.2 nM
In vitro
TAK1/MAP4K2 inhibitor 1 is a highly potent dual inhibitor targeting both TGFβ-activated kinase 1 (TAK1) and MAP kinase kinase kinase kinase 2 (MAP4K2), with IC₅₀ values of 41.1 nM and 18.2 nM, respectively[1].
In vivo
TAK1/MAP4K2 inhibitor 1 (1 mg/kg, iv) has moderate terminal elimination half-life (t1/2=2.94 h) in mice.
Chemical Properties
Molecular Weight552.59
FormulaC29H31F3N6O2
Cas No.1315330-11-0
SmilesO=C(NC1=CC=C(C(=C1)C(F)(F)F)CN2CCN(CC)CC2)C3=CC=C(C(OC4=NC=NC=5NC(=CC45)C)=C3)C
Relative Density.1.319 g/cm3 (Predicted)
Storage & Solubility Information
Storagekeep away from direct sunlight,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 40 mg/mL (72.39 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (3.62 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.8097 mL9.0483 mL18.0966 mL90.4830 mL
5 mM0.3619 mL1.8097 mL3.6193 mL18.0966 mL
10 mM0.1810 mL0.9048 mL1.8097 mL9.0483 mL
20 mM0.0905 mL0.4524 mL0.9048 mL4.5241 mL
50 mM0.0362 mL0.1810 mL0.3619 mL1.8097 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy TAK1/MAP4K2 inhibitor 1 | purchase TAK1/MAP4K2 inhibitor 1 | TAK1/MAP4K2 inhibitor 1 cost | order TAK1/MAP4K2 inhibitor 1 | TAK1/MAP4K2 inhibitor 1 chemical structure | TAK1/MAP4K2 inhibitor 1 in vivo | TAK1/MAP4K2 inhibitor 1 in vitro | TAK1/MAP4K2 inhibitor 1 formula | TAK1/MAP4K2 inhibitor 1 molecular weight